e: info@vacvbtx.com
p: +44 (0)20 809 07585
menu
close

VacV will be attending and presenting at the 8th Investival Showcase which focused on connecting life science and healthcare companies with the investors and partners for growth.

12 Apr 2024
VacV Biotherapeutics promising biotech startup in cancer immunotherapy

February 2024 – “A promising biotech startup in cancer immunotherapy” Labiotech Cancer vaccines: 10 biotech companies that have changed the game

read more +
26 Oct 2022
VacV Biotherapeutics emerges from stealth mode to bring ground-breaking cancer immunotherapies to the clinic

VacV Biotherapeutics (“VacV” or “the Company”), a cancer immunotherapy company developing innovative viral-based therapies, emerged from stealth mode today to advance its promising pipeline of pre-clinical assets with best-in-class potential, towards the clinic.

read more +
e: info@vacvbtx.com
p: +44 (0)20 809 07585
© 2022 VacV Biotheraputics (UK) Ltd. | Design and development by TIG
Privacy Policy